According to a report, worldwide sales of nucleic acid isolation and purification kits were valued at ~US$ 830 million in 2018, and are estimated to register a Y-o-Y growth of ~4% in 2019. As the consistency and reliability of molecular diagnostic results relies heavily on the quality of genetic material i.e. DNA and RNA, manufacturers are focusing on offering high-quality products....
Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) have announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development....
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, have announced they have signed a neurodegeneration drug discovery collaboration agreement. Combining the two companies’ technology platforms to validate novel targets, the initial focus will be on Parkinson’s....
Micromeritics Instrument Corporation has celebrated the opening of its new German subsidiary and European application laboratory "Particle Testing Authority" in Munich-Unterschleissheim in July with invited customers, employees and representatives of local politics. Jeff Sherman, Micromeritics' Vice President Sales and Marketing, and Christoph Böck, First Mayor of Unterschleißheim, inaugurated the new...
SES Water has chosen the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics to manage water testing results in its UKAS-accredited laboratory. SES Water is a water-only company and supplies residents in East Surrey, parts of West Sussex, West Kent and South London in the UK. The laboratory annually performs approximately 120,000 tests...
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has announced it has entered into a structural biology focussed collaboration with the Centre for Chemical Biology and Therapeutics (CCBT), Bangalore, India. CCBT at the Institute for Stem Cell Science and Regenerative Medicine (inStem) is funded by the Department of Biotechnology....
Evotec has announced that the Company has acquired assets from the stem cell specialist Ncardia AG to advance Evotec's iPSC platform, one of the leading iPSC-based discovery platforms in the industry. The acquired assets include intellectual property relevant for iPSC-based phenotypic drug discovery, an existing cellular product business around iPSC-derived cells, as well as 17 strong team of stem cell biology experts...
ImaginAb Inc., a clinical stage immuno-oncology imaging company, announced today that it has entered into a non-exclusive license and collaboration agreement with Roche. Under the terms of the agreement, Roche will use ImaginAb's novel minibody CD8 T cell imaging agent in immuno-oncology clinical trials for multiple types of cancers....
ScreenIn3D, a partner of AMSBIO, has received a share of the £1 million plus prize pot and will receive ongoing support from partners of Scottish Edge - a respected regional business support agency. Scottish EDGE runs a competition aimed at identifying and supporting Scotland’s up-and-coming, innovative, high-growth potential entrepreneurial talent....
BioCity, a pioneering life science incubator and business collective, has announced a new strategic partnership with Oxford AHSN. Working in partnership, the Oxford Academic Health Science Network and BioCity are launching a new Accelerator Programme in Berkshire and South Oxfordshire to catalyse growth in Thames Valley’s world-class health and life sciences cluster by...
Olympus Europe and Cytosurge have partnered in order to accelerate common innovation of next-generation tools for single cell experiments and to expand the distribution of the versatile FluidFM BOT single cell research tool. The ultimate goal of the new co-marketing partnership is to fight diseases and improve human health by enhancing drug development research in pharma, revolutionize single cell gene editing...
The University of Glasgow has benefited from donations worth $7.5m from graduate John Shaw and his wife Kiran Mazumdar-Shaw, who have turned her biotech firm Biocon into one of the largest pharmaceutical firms in India. John Shaw’s donation of $5m to the Research Hub, currently under construction on the Western Infirmary site as part of the University’s £1bn campus development....
Despite being the second most common element in the universe helium has an annoying habit of escaping into space. If this didn’t make things challenging enough, in 1996, the US government started selling off its holding of helium at low prices as it was no longer considered a strategic material. The knock-on effect was a high level of cheap helium on the market.....
A one-day symposium that explores the latest techniques in multi-dimensional chromatography. Leading specialists from industry and academia will explain how they apply the latest 2-D techniques to achieve very difficult separations in the liquid, supercritical fluid, and gas phases. Instrumentation and consumables will be displayed in a comprehensive supporting exhibition from relevant manufacturers....
ROMIL has appointed Paul Stubbings as its UK National Sales Manager to ensure the best possible service for its expanding UK customer base. This newly created role will help to ensure the highest level of customer service for UK customers, and allow Sales Director Anthony Lenk to dedicate more time to the company’s rapidly growing direct sales and distributor-based export markets....
The Native Antigen Company, one of the world’s leading suppliers of reagents that enable research into vaccine development and diagnostics for emerging and endemic infectious diseases, announced today that it has appointed BIOZOL and Shanghai Bioleaf to distribute its high-quality products in Germany, Switzerland and Austria, and China, respectively.....
Biomedical Scientist Cherie Beckett has won the Amazing Individual Award from the Princess Alexandra Hospital NHS Trust. This week, the Princess Alexandra Hospital NHS Trust held their annual Amazing People Awards to recognise staff members who deserve recognition for the amazing work they do. Hundreds of staff members were nominated for these awards....
Integrated DNA Technologies (IDT) announces that it has entered into a strategic cooperation with ChosenMed Technology (Beijing) Co., Ltd (ChosenMed), a medical sequencing firm focused on personalized medicine and transformation healthcare in China. As part of the collaboration, IDT will provide its market-leading NGS enrichment products* for cancer sequencing to ChosenMed, and also help to enhance its scientific research...
Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility, designed and built by WHP. This forms a key part of ADC Bio’s construction of a new bioconjugation facility at its site in Deeside, North Wales, UK for the commercial production of antibody drug conjugates in response to global customer demand....
New high-performance, cost-effective PACE SNP assays will lower the cost and improve the reliability of SNP or indel screening. In the latest collaboration in a series to advocate for genomics research, Integrated DNA Technologies (IDT) is teaming up with 3CR Bioscience (3CR) to widen access to quality custom solutions for genotyping screening. The partnership fuses IDT’s industry-leading oligo synthesis with...
Agilent Technologies Inc. has announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. BioTek is a global leader in the design, manufacture and distribution of innovative life science instrumentation. Its comprehensive product line includes cell imaging systems, microplate readers, washers....
New facility brings rapid, reliable delivery of cell culture media to European customers. FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacture of cell culture media, announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproduction and, cell and gene therapy markets...